Amid concerns about the potential safety and effectiveness of COVID-19 vaccines being developed at a record pace, EU member states are being allowed to indemnify vaccine manufacturers for “certain liabilities,” but there is no room for blanket immunity.
No Blanket Immunity For COVID-19 Vaccine Liabilities, Says EU
Industry Working With Governments On Compensation Systems
As the race to develop COVID-19 vaccines continues, EU member states are ready to financially cover certain of the companies’ risks, but not to change the rules on liability. Transparency proponents are calling for all contracts on vaccine purchases to be made public.
